RxDoctor Payments Data

Brandon Lehr

Physician Assistant · Bradenton, FLNPI 1558992875

Payments from drug & device makers

$6,087in general payments, 2019–2025

Across 295 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$2K
  • Viiv Healthcare Company$2K
  • AbbVie$446
  • Merck$321
  • Johnson & Johnson$319
  • Theratechnologies Inc.$240
  • plus $634 from 13 others

What the payments were for

  • Food & beverage$5,91797%
  • Education$1693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,087 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala556$2,227,490
DovatoDolutegravir Sodium/Lamivudine137$413,472
GenvoyaElviteg/Cob/Emtri/Tenof Alafen77$320,135
EpclusaSofosbuvir/Velpatasvir12$284,568
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf47$250,504
RukobiaFostemsavir Tromethamine26$230,787
TivicayDolutegravir Sodium87$198,962
TriumeqAbacavir/Dolutegravir/Lamivudi47$180,572
OdefseyEmtricitab/Rilpiviri/Tenof Ala50$178,146
DescovyEmtricitabine/Tenofov Alafenam64$144,334
MounjaroTirzepatide124$130,768
OzempicSemaglutide82$93,927
JulucaDolutegravir/Rilpivirine23$86,878
JardianceEmpagliflozin50$61,166
EliquisApixaban51$53,142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Epclusa, Descovy$2,210$2,976,527709 claims
Viiv Healthcare CompanyDovato, Rukobia, Tivicay, Triumeq, Juluca$1,917$1,110,672320 claims
Janssen Products, LPSymtuza$99$250,50447 claims
Lilly USA, LLCMounjaro, Trulicity$41$145,268139 claims
MerckDelstrigo$321$28,69011 claims
GSKTrelegy Ellipta, Anoro Ellipta$22$15,63128 claims
Johnson & JohnsonXarelto$319$14,32714 claims
AbbVieLinzess$446$11,06317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Bradenton

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →